Maximus (MMS) to Release Earnings on Thursday

Maximus (NYSE:MMS) is projected to release its Q1 2026 results before the market opens on Thursday, February 5th. Analysts expect the company to announce earnings of $1.84 per share and revenue of $1.3749 billion for the quarter. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. Individuals are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Thursday, February 5, 2026 at 9:00 AM ET.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.01). The company had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a net margin of 5.87% and a return on equity of 25.23%. Maximus’s revenue was up .2% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.46 earnings per share. On average, analysts expect Maximus to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Maximus Stock Performance

MMS opened at $92.41 on Wednesday. The stock has a market cap of $5.04 billion, a P/E ratio of 16.62 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.64 and a quick ratio of 1.64. The stock’s 50 day simple moving average is $90.31 and its 200 day simple moving average is $86.36. Maximus has a 1-year low of $63.77 and a 1-year high of $100.00.

Maximus Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be issued a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.4%. This is a positive change from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 13th. Maximus’s dividend payout ratio is currently 21.58%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, December 30th. Weiss Ratings restated a “buy (b-)” rating on shares of Maximus in a research report on Monday, December 29th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to data from MarketBeat.com, Maximus has an average rating of “Strong Buy”.

Insider Transactions at Maximus

In other Maximus news, insider Michelle F. Link sold 4,039 shares of the firm’s stock in a transaction dated Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider directly owned 19,542 shares of the company’s stock, valued at $1,697,027.28. This trade represents a 17.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.80% of the company’s stock.

Institutional Trading of Maximus

Hedge funds have recently bought and sold shares of the company. Advisory Services Network LLC acquired a new position in Maximus in the 3rd quarter valued at $32,000. Canada Pension Plan Investment Board purchased a new stake in shares of Maximus in the second quarter valued at $35,000. Danske Bank A S purchased a new stake in shares of Maximus in the third quarter valued at $55,000. National Bank of Canada FI increased its stake in Maximus by 38.9% in the third quarter. National Bank of Canada FI now owns 1,118 shares of the health services provider’s stock valued at $102,000 after purchasing an additional 313 shares during the last quarter. Finally, Wexford Capital LP purchased a new position in Maximus during the third quarter worth about $114,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.